COPENHAGEN — Within the rising tide of studies extolling the benefits of artificial intelligence (AI) for improving adenoma detection during colonoscopy comes new research suggesting the contrary, at least among people with inflammatory bowel disease (IBD). Researchers retrospectively studied almost 1000 colonoscopies before and after introduction of an AI system (GI Genius, Medtronic) at a tertiary medical center in Israel in which a large volume of endoscopies was performed. The adenoma detection rate (ADR) was higher overall with colonoscopies that were performed before the introduciton of AI, and it was significantly higher for colonoscopies performed by gastroenterologists who had 5…
Author: Praveen Suthrum
Breath testing is the most widely utilized modality to diagnose small intestinal bacterial overgrowth (SIBO) and/or intestinal methanogen overgrowth (IMO). Although SIBO can be diagnosed with small bowel aspiration and breath testing, IMO can only be diagnosed with breath testing in clinical practice. Breath testing can tailor antibiotic therapy and predict response to treatment; however, the test is limited by its indirect method of measurement and concerns about the variability of orocecal transit time. Like any clinical test, breath testing has inherent strengths and limitations, and results must be interpreted with consideration of the clinical context and influencing factors. Recent…
IRVINE, Calif., March 08, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced the launch of its InFoods® IBS test. The test is being performed in a CLIA-certified, and CAP accredited high-complexity laboratory facility and offered as a laboratory developed test (LDT). The Company further announced all validation testing necessary for the InFoods IBS product to be offered as an LDT has been completed. The first patient samples have been processed.
Innovative, human-level AI technology will improve efficiency and consistency of Inflammatory Bowel Disease (IBD) scoring, advancing clinical trials of novel treatments for these debilitating ailments. PHILADELPHIA and COPENHAGEN, Denmark and SAN MATEO, Calif. and BOSTON and JERUSALEM, March 6, 2023 /PRNewswire/ — Clario, a leading healthcare research and technology company that generates the richest clinical evidence for the clinical trials industry and GI Reviewers, LLC Gastroenterology consultants and central readers, together with RSIP Vision, an experienced developer of groundbreaking AI technologies for medical imaging, today announced their new AI-based scoring system for inflammatory bowel diseases. The solution is expected to…
As hospitals sever service lines, physician pay continues to drop and supply chain disruptions persist, healthcare industry professionals see both opportunities and challenges going forward. Thirteen healthcare leaders recently connected with Becker’s to discuss how leadership structure at ASCs, hospitals and health systems could be affected by the evolving healthcare landscape.
In 2022 alone, the Remote Patient Monitoring (RPM) market grew to over $50 billion with the market set to exceed $175 billion by the year 2027.1 In recent years, numerous medical studies have concluded better health outcomes and lower costs as a result of RPM programs.2 For providers and payers, treatment plans consisting of RPM for conditions such as diabetes, hypertension, congestive heart failure, and COPD have seen massive improvements in clinical outcomes while yielding cost-savings, and yet RPM had yet to be offered in GI…until now. Today, Salvo Health announces the first-ever RPM offering for chronic GI conditions, including…
Let me be completely upfront: I have an MD degree and an MBA degree. I earned my medical degree in 1980 and my business degree in 1996. I wrote the first definitive textbookopens in a new tab or window about physicians with dual degrees (MD/MBA). Subsequently, I’ve written many papers on the topic, and I maintain articles and news clippings in several file folders, each 3 to 4 inches thick. I keep track of current trends. I encourage medical students and early career physicians to apply to business school if they have a genuine interest in the business and management…
The new locations are Nashville, Smyrna, and Hendersonville and a fourth one is planned in Clarksville, Tennessee. NASHVILLE, TENNESSEE, UNITED STATES, March 2, 2023 /EINPresswire.com/ — Digestive and Liver Health Specialists, a premier gastroenterology practice, is proud to announce its expansion throughout Middle Tennessee. The practice offers the only state-of-the-art 360-degree viewing endoscopy technology in the state of Tennessee, along with three convenient locations in Nashville, Smyrna, and Hendersonville, Tennessee, and a fourth planned location in Clarksville, Tennessee. These new locations will provide patients with close and convenient care, allowing them to receive the expert gastroenterology and hepatology care they…
Franklyn Rocha Cabrero M.D. graduated from his neurophysiology fellowship last year already knowing he didn’t want the same lifestyle as his attending physicians. He often saw them working past 10 p.m. writing notes. They seemed to have little autonomy to make their own decisions. Junior doctors in particular seemed to be getting the short end of the stick. “Everyone surrounding me was burned out and I did not want to go through that cycle,” Cabrero said. Instead, he decided to become a free agent. Read More
What does the future of GI care look like? How will advancements in healthcare policies and technology, including AI, impact the GI community? Four GI leaders share their insights. Read More